Molecular Diagnostics and Treatment of Pancreatic Cancer

Name: Molecular Diagnostics and Treatment of Pancreatic Cancer
Price: 874.00 SEK
Availability: InStock
Author: Asfar Azmi
ISBN: 9780124081031

Systems and Network Biology Approaches

av Asfar Azmi

Inbunden, Engelska, 2014-04-17

874

Köp

Spara som favorit

Skickas från oss inom 7-10 vardagar.
Fri frakt över 249 kr för privatkunder i Sverige.

Finns även som

E-bok (LCP)

Ladda ned och läs i Bokus Reader.

1095

Visa alla 1 format & utgåvor

Molecular Diagnostics and Treatment of Pancreatic Cancer describes the different emerging applications of systems biology and how it is shaping modern pancreatic cancer research. This book begins by introducing the current state of the art knowledge, trends in diagnostics, progress in disease model systems as well as new treatment and palliative care strategies in pancreatic cancer. Specific sections are dedicated to enlighten the readers to newer discoveries that have emerged from gene expression profiling, proteomics, metabolomics and systems level analyses of pancreatic cancer datasets. First of a kind and novel network strategies to understand oncogenic Kras signaling in pancreatic tumors are presented. The attempts to computationally model and prioritize microRNAs that cause pancreatic cancer resistance are also highlighted.

Addressing this important area, Molecular Diagnostics and Treatment of Pancreatic Cancer provides insights into important network evaluation methodologies related to pancreatic cancer related microRNAs targetome. There are dedicated chapters on critical aspects of the evolving yet controversial field of pancreatic cancer stems cells. The work concludes by discussing the applications of network sciences in pancreatic cancer drug discovery and clinical trial design.

Encompasses discussion of innovative tools including expression signatures in cell lines, 3D models, animal xenograft models, primary models and patient derived samples, aiding subversion of traditional biology paradigms, and enhancing comprehension across conventional length and temporal scales
Coverage includes novel applications in targeted drugs, polypharmacology, network pharmacology and other related drug development arenas - helping researchers in pancreatic cancer drug discovery
Summarizes many relevant computational and clinical references from fast-evolving literature
Comprehensive glossary helps newer readers understand technical terms and specialized nomenclature

Visa hela texten

Passar bra ihop

De som köpt den här boken har ofta också köpt Animal Models in Cancer Drug Discovery av Asfar Azmi, Ramzi M Mohammad (häftad).

Köp båda 2 för 2602 kr

Conquering RAS

Asfar Azmi

Conquering RAS: From Biology to Cancer Therapy provides introductory knowledge on how modern RAS biology is taking shape in light of newer technological development. Each chapter is written in a manner that emphasizes simplicity and readability fo...

1402

Köp

Skickas inom vardagar.
Animal Models in Cancer Drug Discovery

Asfar Azmi, Ramzi M Mohammad

Animal Models in Cancer Drug Discovery brings forward the most cutting-edge developments in tumor model systems for translational cancer research. The reader can find under this one volume virtually all types of existing and emerging tumor models ...

1728

Köp

Skickas inom vardagar.

Asfar Azmi, PhD, is an Assistant Professor at the Department of Oncology, Wayne State University. He has more than a decade of research experience in the area of cancer biology and drug discovery. Dr. Azmi's lab has made significant pre-clinical discoveries in advanced animal tumor models that helped the clinical development of new cancer drugs. Dr. Azmi has considerable experience in the area of early phase clinical research. Several agents developed by his team have gone into Phase II clinical studies. He has published more than 100 cancer research articles and has edited three additional books, among which there are the Elsevier publications Molecular Diagnostics and Treatment of Pancreatic Cancer as well as Conquering Ras. He is the recipient of numerous young investigator awards from premier scientific bodies. The National Institute of Health and pharmaceutical industry have continuously funded his lab.